(R)-(-)-1-Aminoindan

We are (R)-(-)-1-Aminoindan CAS:10277-74-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(R)-(-)-1-Aminoindan
CAS.NO:10277-74-4
Synonyms:(R)-(-)-1-Aminoindan
(1R)-2,3-dihydro-1H-inden-1-amine
(R)-2,3-Dihydro-1H-inden-1-amine
(R)-1-Aminoindane
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 225.0±19.0 °C at 760 mmHg
Melting Point 15ºC
Molecular Formula C9H11N
Molecular Weight 133.190
Flash Point 94.4±0.0 °C
 
Specification:
Appearance:Colorless to light yellow clear liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rasagiline Mesylate(CAS:161735-79-1).

(R)-(-)-1-Aminoindan


Related News: Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.2-Cyano-6-methylpyridine Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide,2,2,2-trifluoroacetic acid Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).21643-42-5 “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.“Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.

Related Products
Product Name
1-bromo-9-fluorononane View Details
Arbutin View Details
Methyl Valeraldehyde View Details
2,6-Diaminopyridine sulfate manufacturer 2-Nitroaminoimidazoline manufacturer 2-methyl-5-(trifluoromethyl)aniline manufacturer 4-ethoxy-2,3-difluorobenzonitrile manufacturer ethyl 2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylate manufacturer